149 related articles for article (PubMed ID: 28551532)
1. Effects of tryptophan, kynurenine and kynurenic acid exerted on human reconstructed corneal epithelium in vitro.
Matysik-Woźniak A; Paduch R; Turski WA; Maciejewski R; Jünemann AG; Rejdak R
Pharmacol Rep; 2017 Aug; 69(4):722-729. PubMed ID: 28551532
[TBL] [Abstract][Full Text] [Related]
2. Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells-In Vitro Studies.
Walczak K; Langner E; Makuch-Kocka A; Szelest M; Szalast K; Marciniak S; Plech T
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114713
[TBL] [Abstract][Full Text] [Related]
3. Examination of Kynurenine Toxicity on Corneal and Conjunctival Epithelium: In vitro and in vivo Studies.
Matysik-Woźniak A; Turski WA; Turska M; Paduch R; Łańcut M; Piwowarczyk P; Czuczwar M; Jünemann A; Rejdak R
Ophthalmic Res; 2019; 62(1):24-35. PubMed ID: 30970363
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
5. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan and its metabolite, kynurenine, stimulate expression of nerve growth factor in cultured mouse astroglial cells.
Dong-Ruyl L; Sawada M; Nakano K
Neurosci Lett; 1998 Mar; 244(1):17-20. PubMed ID: 9578134
[TBL] [Abstract][Full Text] [Related]
7. A Simple HPLC-MS/MS Method for Determination of Tryptophan, Kynurenine and Kynurenic Acid in Human Serum and its Potential for Monitoring Antidepressant Therapy.
Hu LJ; Li XF; Hu JQ; Ni XJ; Lu HY; Wang JJ; Huang XN; Lin CX; Shang DW; Wen YG
J Anal Toxicol; 2017 Jan; 41(1):37-44. PubMed ID: 27590037
[TBL] [Abstract][Full Text] [Related]
8. The analgesic effects of tryptophan and its metabolites in the rat.
Heyliger SO; Goodman CB; Ngong JM; Soliman KF
Pharmacol Res; 1998 Oct; 38(4):243-50. PubMed ID: 9774487
[TBL] [Abstract][Full Text] [Related]
9. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas.
Nicholls T; Nitsos I; Smythe G; Walker DW
Am J Obstet Gynecol; 2001 Oct; 185(4):988-95. PubMed ID: 11641690
[TBL] [Abstract][Full Text] [Related]
11. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
Rozsa E; Robotka H; Nagy D; Farkas T; Sas K; Vecsei L; Toldi J
Brain Res Bull; 2008 Jul; 76(5):474-9. PubMed ID: 18534254
[TBL] [Abstract][Full Text] [Related]
12. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.
Swartz KJ; During MJ; Freese A; Beal MF
J Neurosci; 1990 Sep; 10(9):2965-73. PubMed ID: 2168940
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
Bortolotti P; Hennart B; Thieffry C; Jausions G; Faure E; Grandjean T; Thepaut M; Dessein R; Allorge D; Guery BP; Faure K; Kipnis E; Toussaint B; Le Gouellec A
BMC Microbiol; 2016 Jul; 16(1):137. PubMed ID: 27392067
[TBL] [Abstract][Full Text] [Related]
14. A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes.
Szelest M; Walczak K; Plech T
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499346
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan as a Safe Compound in Topical Ophthalmic Medications:
Matysik-Woźniak A; Turski WA; Turska M; Paduch R; Łańcut M; Piwowarczyk P; Czuczwar M; Rejdak R
Ocul Immunol Inflamm; 2022 May; 30(4):940-950. PubMed ID: 33616466
[TBL] [Abstract][Full Text] [Related]
16. Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway.
Zsizsik BK; Hardeland R
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Nov; 133(3):383-92. PubMed ID: 12379423
[TBL] [Abstract][Full Text] [Related]
17. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
[TBL] [Abstract][Full Text] [Related]
19. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
20. Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes.
Liu JJ; Ching J; Wee HN; Liu S; Gurung RL; Lee J; M Y; Zheng H; Lee LS; Ang K; Shao YM; Kovalik JP; Subramaniam T; Sum CF; Sharma K; Kestenbaum BR; Lim SC
Diabetes Care; 2023 Dec; 46(12):2223-2231. PubMed ID: 37796480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
